Skip to Main Content (Press Enter)
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
IT
EN
☰
UNIFIND
|
UNIFIND
unisr.it
IT
EN
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
☰
Pubblicazioni
THE LANCET ONCOLOGY
Rivista
Codice:
E098908
ISSN:
1470-2045
Dati Generali
Dati Generali
Pubblicazioni (58)
Pulisci
Ordina Pubblicazioni:
crescente
decrescente
A gap analysis of opportunities and priorities for breast surgical research
Articolo
APX005M, a CD40 monoclonal antibody, for patients with pancreatic adenocarcinoma
Articolo
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial
Articolo
Anal cancer: from an orphan disease to a curable malignancy?
Articolo
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study
Articolo
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
Articolo
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
Articolo
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial
Articolo
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
Articolo
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
Articolo
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox
Articolo
CNS prophylaxis for diffuse large B-cell lymphoma
Articolo
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II tria
Articolo
Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial
Articolo
Consensus on molecular imaging and theranostics in prostate cancer
Articolo
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease
Articolo
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
Articolo
Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial
Articolo
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
Articolo
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
Articolo
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Articolo
Ibrutinib holds promise for patients with 17p deletion CLL
Articolo
Ibrutinib: better combined with other drugs?
Articolo
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial
Articolo
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study
Articolo
Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.
Articolo
Justifying vein resection with pancreato-duodenectomy
Articolo
Knowledge gaps in oncoplastic breast surgery
Articolo
Maintenance therapy for metastatic colorectal cancer
Articolo
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
Articolo
Molecular imaging targeting carbonic anhydrase 9 in clear-cell renal cell carcinoma: more than meets the eye
Articolo
Neoadjuvant sacituzumab govitecan plus pembrolizumab, followed by adjuvant pembrolizumab, in patients with muscle-invasive bladder cancer (SURE-02): a single-arm, phase 2 study
Articolo
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
Articolo
Pancreatic cancer: still a cold case?
Articolo
Pancreatic metastasis from leiomyosarcoma of the broad ligament of the uterus.
Articolo
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study
Articolo
Patience and commitment needed to fight very rare tumours
Articolo
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial
Articolo
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
Articolo
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial
Articolo
Quality of life after video-assisted surgery for lung cancer.
Articolo
Radiotherapy for renal-cell carcinoma
Articolo
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
Articolo
Recommendations for management of patients with neuroendocrine liver metastases
Articolo
Salvage radiotherapy for patients with rising PSA
Articolo
Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS)
Articolo
Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial
Articolo
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies
Articolo
Targeted therapies make room, anti-CD79b agents are coming
Articolo
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Articolo
The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer—a multidisciplinary consensus
Articolo
The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer
Articolo
The emerging role of PET-CT scan after radical prostatectomy: still a long way to go
Articolo
The immune system and response to HER2-targeted treatment in breast cancer.
Articolo
The importance of the extent of pelvic-lymph-node dissection in the diagnosis of lymph-node metastases in prostate cancer
Articolo
Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial
Articolo
Timing of androgen-deprivation therapy for prostate cancer: still a long way to go
Articolo
Whole-brain radiotherapy in primary CNS lymphoma
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
